Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06877884 · ClinicalTrials.gov registry record
A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data
A clinical trial of Cancer, sponsored by N-Power Medicine.
- Recruiting
- Registry status
- 20,000
- Enrollment target
- 7
- Study locations
NCT06877884: Recruiting study of Cancer, sponsored by N-Power Medicine.
NCT06877884 is a study of Cancer that is actively recruiting participants, run by N-Power Medicine. The registered enrollment target is 20,000 participants, above the 3,459-participant average among 615 other Cancer trials with a reported enrollment target (478% higher). The trial reports 7 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06877884, a study of Cancer, is actively recruiting participants, sponsored by N-Power Medicine.
- RECRUITING
- Registry status
- 20,000 participants
- Enrollment target
- 7
- Study locations
Study Summary
This is an observational registry for patients at participating oncology centers. The data collection includes but is not limited to baseline variables, treatments given and outcome data. Patient surveys are also included. The aim of the study is to generate rich and standardized data for patients and to help enable more patients participate in clinical trials and contribute to research and development.
Primary Outcome
Effectiveness outcomes of treatments used in routine clinical care (such as for instance time to treatment discontinuation ) will be captured
Conditions Studied
Study Locations (7)
Delaware
- Bayhealth Cancer Center-Kent - Dover
- Bayhealth Cancer Center- Sussex - Milford
California
- Pacific Cancer Care - Monterey
Illinois
- Northwest Oncology & Hematology - Elk Grove Village
New Mexico
- New Mexico Oncology Hematology Consultants - Albuquerque
Pennsylvania
- Lankenau Medical Center - Paoli
Texas
- Oncology Consultants, P.A. - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,000 participants |
| Start Date | 2022-08-01 |
| Est. Completion | 2099-01 |
What NCT06877884 shows while recruiting
NCT06877884 is an observational study that tracks outcomes without assigning an intervention. Its 20,000 participants enrollment target places it among the larger protocols in the corpus, above the 3,459-participant average among 615 other Cancer trials with a reported enrollment target (478% higher).
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT06877884 lists 7 locations in 6 states (Delaware, California, Illinois).
Frequently Asked Questions
What is clinical trial NCT06877884 about?
NCT06877884 is a clinical study titled "A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data". This is an observational registry for patients at participating oncology centers. The data collection includes but is not limited to baseline variables, treatments given and outcome data. Patient surveys are also included. The aim of the study is to generate rich and standardized data for patients a...
What is the current status of trial NCT06877884?
This trial is currently recruiting. The enrollment target is 20,000 participants. The study started on 2022-08-01. Estimated completion is 2099-01.
What conditions does trial NCT06877884 study?
This clinical trial studies the following conditions: Cancer.
Who is sponsoring clinical trial NCT06877884?
This trial is sponsored by N-Power Medicine, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06877884 being conducted?
This trial has 7 study locations across California, Delaware, Illinois, New Mexico, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06877884's enrollment target sits among peer trials
20,000 17th of 615 higher than 599 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00271180 · 20,000 participants
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- NCT00830557 · 20,000 participants
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
- NCT00900471 · 20,000 participants
Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
- NCT02735707 · 20,000 participants · Phase 3
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI